INIA Biosciences
INIA Biosciences develops non-invasive, home-administered medical devices that use sound waves to modulate the immune system for managing chronic inflammatory diseases. The company's closed-loop platform combines treatment with home monitoring, enabling patients to manage their condition without frequent clinic visits. Their approach represents an emerging application of bioelectronic medicine that harnesses acoustic signals to influence immune response.
- Digital Health
- Hardware
- Healthcare Technology
- Medical Devices
- Software Only
Funding
Raised to date
€1.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Est. $1.4Macross 1 round
BI€1.3M · Grant
Announced Sep 2026 · from article date
Disclosed cumulative: $1.4M
Founders
Renee Ryan
Co-Founder
Dragana Savic
Co-Founder
Product
Problem
Chronic inflammatory diseases require ongoing management, yet current treatment options often involve invasive procedures, frequent clinical visits, or systemic medications with significant side effects. Patients lack convenient, accessible methods to modulate their immune response from home, creating barriers to consistent disease management and reducing quality of life.
Solution
INIA Biosciences develops non-invasive, home-administered medical devices that use precisely calibrated sound waves to modulate immune system activity. The closed-loop system monitors patient responses and automatically adjusts treatment parameters, creating a personalized therapeutic approach for managing chronic inflammatory conditions. By enabling patients to administer treatment at home, the platform reduces dependence on clinical infrastructure while maintaining therapeutic oversight through integrated monitoring capabilities. The technology applies principles of bioelectronic medicine, using acoustic signals to influence neural pathways that regulate inflammatory responses.
Target Audience
Primary users are patients with chronic inflammatory diseases who need ongoing immune modulation therapy, along with healthcare providers seeking non-invasive treatment alternatives for their patients.
Features
- Non-invasive sound wave technology that targets immune system modulation without surgical implantation
- Closed-loop system with automatic treatment adjustment based on patient response monitoring
- Home-administered design that eliminates the need for frequent clinical visits
- Integrated home-monitoring capabilities for tracking disease status and treatment efficacy
- Platform architecture designed for chronic inflammatory disease management across multiple conditions